Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic

Following onset of the first recorded case of Coronavirus disease 2019 (COVID-19) in December 2019, more than 269 million cases and over 5.3 million deaths have been confirmed worldwide. COVID-19 is a highly infectious pneumonia, caused by a novel virus called severe acute respiratory syndrome coron...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xianghui, Zhang, Yabo, He, Libing, Si, Jiangzhe, Qiu, Shuai, He, Yuhua, Wei, Jiacun, Wang, Zhili, Xie, Longxiang, Li, Yanzhang, Teng, Tieshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935217/
https://www.ncbi.nlm.nih.gov/pubmed/35342348
http://dx.doi.org/10.7150/ijbs.66369
_version_ 1784671999147114496
author Li, Xianghui
Zhang, Yabo
He, Libing
Si, Jiangzhe
Qiu, Shuai
He, Yuhua
Wei, Jiacun
Wang, Zhili
Xie, Longxiang
Li, Yanzhang
Teng, Tieshan
author_facet Li, Xianghui
Zhang, Yabo
He, Libing
Si, Jiangzhe
Qiu, Shuai
He, Yuhua
Wei, Jiacun
Wang, Zhili
Xie, Longxiang
Li, Yanzhang
Teng, Tieshan
author_sort Li, Xianghui
collection PubMed
description Following onset of the first recorded case of Coronavirus disease 2019 (COVID-19) in December 2019, more than 269 million cases and over 5.3 million deaths have been confirmed worldwide. COVID-19 is a highly infectious pneumonia, caused by a novel virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, it poses a severe threat to human health across the globe, a trend that is likely to persist in the foreseeable future. This paper reviews SARS-CoV-2 immunity, the latest development of anti-SARS-CoV-2 drugs as well as exploring in detail, immune escape induced by SARS-CoV-2. We expect that the findings will provide a basis for COVID-19 prevention and treatment.
format Online
Article
Text
id pubmed-8935217
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-89352172022-03-24 Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic Li, Xianghui Zhang, Yabo He, Libing Si, Jiangzhe Qiu, Shuai He, Yuhua Wei, Jiacun Wang, Zhili Xie, Longxiang Li, Yanzhang Teng, Tieshan Int J Biol Sci Review Following onset of the first recorded case of Coronavirus disease 2019 (COVID-19) in December 2019, more than 269 million cases and over 5.3 million deaths have been confirmed worldwide. COVID-19 is a highly infectious pneumonia, caused by a novel virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, it poses a severe threat to human health across the globe, a trend that is likely to persist in the foreseeable future. This paper reviews SARS-CoV-2 immunity, the latest development of anti-SARS-CoV-2 drugs as well as exploring in detail, immune escape induced by SARS-CoV-2. We expect that the findings will provide a basis for COVID-19 prevention and treatment. Ivyspring International Publisher 2022-02-14 /pmc/articles/PMC8935217/ /pubmed/35342348 http://dx.doi.org/10.7150/ijbs.66369 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Review
Li, Xianghui
Zhang, Yabo
He, Libing
Si, Jiangzhe
Qiu, Shuai
He, Yuhua
Wei, Jiacun
Wang, Zhili
Xie, Longxiang
Li, Yanzhang
Teng, Tieshan
Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
title Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
title_full Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
title_fullStr Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
title_full_unstemmed Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
title_short Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic
title_sort immune response and potential therapeutic strategies for the sars-cov-2 associated with the covid-19 pandemic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935217/
https://www.ncbi.nlm.nih.gov/pubmed/35342348
http://dx.doi.org/10.7150/ijbs.66369
work_keys_str_mv AT lixianghui immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT zhangyabo immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT helibing immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT sijiangzhe immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT qiushuai immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT heyuhua immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT weijiacun immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT wangzhili immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT xielongxiang immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT liyanzhang immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic
AT tengtieshan immuneresponseandpotentialtherapeuticstrategiesforthesarscov2associatedwiththecovid19pandemic

Ejemplares similares